/Investor DB

New Enterprise Associates (NEA) — 2024 Investments

26 investments dated 2024 · listed companies and verified rows first · show all

Onkure Therapeutics Inconkuretherapeutics.comin𝕏NASDAQ: OKUROct 2024

OnKure Therapeutics is a clinical-stage biopharmaceutical company developing PI3Kα pan-mutant selective inhibitor medicines for the treatment of breast cancer and vascular anomalies.

BiotechDigital HealthHealthtechMedical DevicesBoulder, US

Jason Leverone(Executive Officer)inSamuel Agresta(Executive Officer)inDylan Hartley(Executive Officer)inWendy Johnson(Executive Officer)Nicholas A. Saccomano(President and Chief Executive Officer and Director)

BoardIsaac Manke(Director)in

Board seatEdward T. Mathers· per SEC Form D

Co-investorsAccess BiotechnologyBoulder VenturesRiverVest Venture PartnersAbingworthACORN BIOVENTURESNovo Holdings

Metronomemetronome.comin𝕏Series B · Jan 2024 · $43M✓ verifiedAcquired

Metronome provides a usage-based billing platform for SaaS companies, enabling them to launch products faster and make data-driven revenue decisions.

Data & InfrastructureEnterprise SoftwareFintechSaaS

Scott Woody(CEO)inAndrew Garvin(Founder)inKevin Liu(Founder)

Co-investorsAndreessen HorowitzGeneral CatalystElad GilActivant CapitalMango CapitalNat Turner+5 more

Moximedmoximed.comSeed · Aug 2024

HealthtechFremont, US

Anton Clifford(Executive Officer)inJames Leech(Executive Officer)inChristopher Gleason(Executive Officer)inKevin K. Sidow(Executive Officer, Director)

BoardShahzad Malik(Director)in

Board seatJoshua Makower· per SEC Form D

Co-investorsLightstone VenturesRunway Growth CapitalAdvent Life SciencesGBS Venture Partners Ltd.Gilde HealthcareMorgenthaler+1 more

PayZenpayzen.comin𝕏Series B · Sep 2024 · $32M

PayZen provides AI-powered, interest-free patient financing that lets patients pay medical bills over time through personalized payment plans, with pre-built EHR integrations and automated servicing for providers.

AI & Machine LearningDigital HealthFintechHealthtechSan Francisco, US

Tobias Mezger(Founder)inIsaac Cohen(Executive Officer, Director)Ariel Rosenthal(Founder)inItzik Cohen(Founder)inAntonio Martino(Executive Officer)in

BoardLee Shapiro(Director)in

Board seatMohamad Makhzoumi· per SEC Form D

Co-investors7wire VenturesSignalFireCorewell Health VenturesHaymaker VenturesLink VenturesLorimer Ventures+4 more

Twelve Labstwelvelabs.ioin𝕏Series A · Apr 2024 · $50M

Twelve Labs develops AI technology for video understanding, enabling machines to comprehend and analyze video content for applications in human-machine interaction and perception.

AI & Machine LearningData & InfrastructureMedia & EntertainmentSan Francisco, US

Aiden Lee(Founder)Jae Sung Lee(Executive Officer, Director)Seung Joon Lee(Executive Officer, Director)Jin Woo Chung(Executive Officer, Director)Soyoung Lee(Executive Officer, Director)inAiden L.(Founder)in

Board seatTiffany Luck· per SEC Form D

Co-investorsavraExpaHan River PartnersHillspring InvestmentHubSpot VenturesIn-Q-Tel+18 more

Agreeagree.comin𝕏Sep 2024

Agree offers a platform that connects contracts, billing, and payments so companies can convert signed deals into revenue automatically, with automated invoicing, payment collection, dunning, and real-time revenue and cash-flow visibility.

AI & Machine LearningEnterprise SoftwareFintechSaaSSales TechSan Francisco, US

Will Hubbard(Co-founder)inEvan Dudla(Co-founder)inMarty Ringlein(Co-founder)in

Co-investors8-Bit CapitalBetter Tomorrow VenturesEverywhere VenturesExpedite VenturesFirsthandVCTrust Fund+5 more

AI Squaredsquared.aiinSeed · Apr 2024 · $13.8M

AISquared provides an enterprise platform (UNIFI) to build, deploy, and govern agentic AI workflows across existing business systems, connecting trusted data, orchestration, embedded delivery, security, and analytics.

AI & Machine LearningEnterprise SoftwareSaaSSan Francisco, US

Jacob Renn(Founder)inBenjamin Harvey, Ph.D.(Founder)inBenjamin Harvey(Founder)in

Co-investorsAnsa CapitalLatimer Ventures

Amber Therapeuticsamber-tx.cominSeries A · Jun 2024 · $100M

Amber Therapeutics develops medical technology focused on treating mixed urinary incontinence, advancing toward pivotal clinical trials in the US with expanded feasibility studies in Europe.

Medical Devices

Co-investorsF-Prime CapitalIntuitive VenturesLightstone VenturesOxford Science Enterprises

Avenzoavenzotx.cominNov 2024

Avenzo Therapeutics is a clinical-stage biopharmaceutical company developing therapeutic treatments.

BiotechSan Diego, US

Athena Countouriotis(Co-Founder, Chief Executive Officer)Mohammad Hirmand(Executive Officer)inPaolo Tombesi(Executive Officer)inScott Lipman(Executive Officer)inBrian Sun(Executive Officer)in

BoardCarl Gordon(Director)

Co-investorsDelos CapitalForesite CapitalINCE CapitalLongwood FundOrbiMedQuan Capital+6 more

beehiivbeehiiv.comin𝕏Series B · Apr 2024 · $33M

beehiiv is a publishing platform for creators, publishers, and brands to build and grow newsletters, websites, podcasts, and communities.

Creator EconomyMarketing TechMedia & EntertainmentSaaSNew York, US

Jake Hurd(Founder)Tyler Denk(Founder)inBenjamin Hargett(Founder)inBen Hargett(Founder)

Co-investors359 CapitalAdventure FundBlue Wire CapitalBrexCollectivConnect Ventures+11 more

Cardurioncardurion.cominJul 2024 · $260M

Cardurion is a cardiovascular disease-focused company developing therapeutics, with a pipeline advanced through clinical development, trial design, regulatory affairs, and commercialization.

BiotechDigital HealthHealthtechMedical DevicesBurlington, US

Michael E. Mendelsohn(Founder and Chief Strategy Officer)in

Co-investorsBain CapitalAscenta CapitalDelos CapitalDigitalis VenturesBain Capital Life SciencesBain Capital Tech Opportunities+4 more

Comanche Biopharmacomanchebiopharma.cominSeed · Jan 2024 · $75M

Comanche Biopharma is a biopharmaceutical company developing an investigational siRNA medicine (CBP-4888) targeting a root cause of preterm preeclampsia in pregnant women.

BiotechFemTechHealthtechConcord, US

Mike Young(Founder)inT Scott Johnson(Founder)inPaul Antinori(Executive Officer)Allison August(Executive Officer)inThomas Scott Johnson(Executive Officer, Director)

BoardBrendan Bulik-Sullivan(Director)in

Co-investorsAtlas VentureGV (Google Ventures)Broadview VenturesF-Prime CapitalLilly Asia Ventures

Dandelion Healthdandelionhealth.aiinFeb 2024

Dandelion Health develops clinical AI applications by combining healthcare domain expertise with machine learning research to advance AI adoption in healthcare.

AI & Machine LearningDigital HealthHealthtechSyosset, US

Elliott Green(Co-founder and CEO)in

BoardSam Toole(Director)inNiyum Gandhi(Co-founder and Board Chair)inSendhil Mullainathan(Co-founder and Scientific Advisor)inZiad Obermeyer(Co-founder and Chief Scientific Officer)

Co-investorsColle Capital PartnersConvergent VenturesFloating PointHealthier CapitalMoxxie VenturesPrimary Venture Partners

DeltaStreamdeltastream.ioin𝕏Series A · Sep 2024 · $15M

DeltaStream provides a real-time context layer that continuously computes live, time-aware context from streaming data and delivers it to enterprise AI agents, and it builds AI agents that connect to internal systems and act on current data.

AI & Machine LearningData & InfrastructureEnterprise SoftwareMenlo Park, US

Hojjat Jafarpour(Founder)in

Co-investorsGalaxy Interactive

Genmogenmo.aiin𝕏Feb 2024

Genmo is a research lab building frontier AI models for video generation, positioning its models as world simulators for embodied AI and synthetic environments.

AI & Machine LearningCreator EconomyDeep TechMedia & EntertainmentSan Francisco, US

Ajay Jain(Founder)inParas Jain(Founder)in

Co-investorsAngel Collective Opportunity FundEastlink Capital PartnersESSENCE VCEssence Venture CapitalGold House VenturesHouse+1 more

Habitat Healthhabitathealth.cominSep 2024 · $50M

Habitat Health operates PACE (Program of All-Inclusive Care for the Elderly) centers offering medical care, social services, home care, and transportation for adults age 55 and older.

Digital HealthHealthtechLongevitySan Francisco, US

Robert Fuentes(Founder)in

Co-investorsKaiser Permanente VenturesTown Hall Ventures

In-House Healthinhouse.healthin𝕏Seed · May 2024 · $4M

In-House builds AI-driven predictive scheduling software for hospital nursing teams, forecasting patient census, acuity, and shift-level workload to automate and balance staffing.

AI & Machine LearningHealthtechHR TechSaaSNew York City, US

Shachar Har Zvi(Founder)inAri Brenner(Executive Officer, Director)

Co-investorsLongevity Venture PartnersTMVVine Ventures

Propense AIpropense.aiinMar 2024

Propense provides AI-powered recommendations to professional services firms (accounting, law, consulting) that identify cross-selling opportunities and client needs by analyzing firm data and market signals.

AI & Machine LearningEnterprise SoftwareSaaSMiami, US

Alexander Diaz Fraenkel(Founder)in

Co-investorsFlorida Opportunity FundHarlem Capital PartnersOperator CollectiveThomson Reuters VenturesDeepWork CapitalHarlem Capital

Regulusregulus-technologies.co.jpMar 2024 · $100M

Regulus is a Japanese company working on recruiting automation software.

Future of WorkHR Tech

Max Koenig

Co-investors500 GlobalSierra VenturesCanaan Partners IsraelF2 Venture CapitalRA CapitalVivo Capital

Sora Schoolssoraschools.comin𝕏Feb 2024

Sora Schools provides an engaging, personalized learning experience built by educators, designers, and engineers.

EdTechAtlanta, US

Indra Sofian(Director)inWesley Samples(Executive Officer, Director)Garrett Smiley(Founder)in

BoardTed Dintersmith(Director)Rebecca Kaden(Director)inMichael Lynton(Director)

Co-investorsContraryGaingelsHoneystone VenturesInspired CapitalUnion Square Ventures (USV)CRV (Charles River Ventures)+6 more

Xaira Therapeuticsxaira.comin𝕏Series A · Apr 2024 · $1B

Xaira develops AI and machine learning tools for drug discovery and protein design, serving pharmaceutical and biotech companies.

AI & Machine LearningBiotechMedical DevicesSouth San Francisco, US

Hetu Kamisetty(Founder)Marc Tessier-Lavigne(Founder)inDr. Ci Chu(Chief Discovery Officer)Dr. Bo Wang(Chief AI Scientist)Dr. Ian McCaffery(SVP, Translational Science and Early Clinical Development)Bob Nelsen(Founder)

Co-investorsARCH Venture PartnersBreyer CapitalDeviation CapitalF-Prime CapitalForesite CapitalLongwood Fund+5 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Stable Coin Inc.Brenig Therapeutics, Inc.Cardurion PharmaceuticalsCrewLABTwenty (YC S23)

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.